Verimmune

Developer of vaccines for the treatment of cancer

placeBaltimore, Maryland, United States calendar_todayFounded 2019 groups7 employees language verimmune.com

Registered entities

Social engagement

Social engagement: 1.5K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Beiley Biofund, Proxima Ventures, SeedFolio.

Investor typeCountShare
Venture capital660%
Private equity110%
Other / undisclosed330%

Recent activity

10 Jun 2026
Recognition
25 Feb 2026
Recognition
21 Jan 2026
Event
World Wide Event
Coming soon